Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||ATLCAR.CD30.CCR4 cells|
ATLCAR.CD30.CCR4 cells are autologous T-lymphocytes that are engineered to express CCR4 linked to a chimeric antigen receptor that recognizes CD30 and the co-stimulatory domains of CD28 and CD3zeta, which potentially results in increased immune response against CD30-expressing tumor cells (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|ATLCAR.CD30 cells + ATLCAR.CD30.CCR4 cells||ATLCAR.CD30 cells ATLCAR.CD30.CCR4 cells||0||1|
|ATLCAR.CD30.CCR4 cells||ATLCAR.CD30.CCR4 cells||0||1|